146 related articles for article (PubMed ID: 38300612)
21. Marginal zone lymphomas.
Zucca E; Rossi D; Bertoni F
Hematol Oncol; 2023 Jun; 41 Suppl 1():88-91. PubMed ID: 37294969
[TBL] [Abstract][Full Text] [Related]
22. Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma.
Gupta N; Roychoudry S; Sticco KL; Hsu P; Zhang X; Sheikh-Fayyaz S
Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):217-223. PubMed ID: 36867739
[TBL] [Abstract][Full Text] [Related]
23. Primary spinal marginal zone lymphoma: case report and review of the literature.
Ahmadi SA; Frank S; Hänggi D; Eicker SO
Neurosurgery; 2012 Aug; 71(2):E495-508; discussion E508. PubMed ID: 22314752
[TBL] [Abstract][Full Text] [Related]
24. Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.
Tam CS; Prince HM; Westerman D; Seymour JF; Juneja S
Leuk Lymphoma; 2004 Apr; 45(4):705-10. PubMed ID: 15160943
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma.
Teckie S; Qi S; Chelius M; Lovie S; Hsu M; Noy A; Portlock C; Yahalom J
Ann Oncol; 2017 May; 28(5):1064-1069. PubMed ID: 28327924
[TBL] [Abstract][Full Text] [Related]
26. [Current management of marginal zone lymphomas].
Bonnet C; Lejeune M; Van Kemseke C; Bron D; Beguin Y
Rev Med Suisse; 2015 Aug; 11(483):1549-56. PubMed ID: 26502581
[TBL] [Abstract][Full Text] [Related]
27. Marginal zone lymphoma.
Shaye OS; Levine AM
J Natl Compr Canc Netw; 2006 Mar; 4(3):311-8. PubMed ID: 16507274
[TBL] [Abstract][Full Text] [Related]
28. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.
Martinelli G; Ryan G; Seymour JF; Nassi L; Steffanoni S; Alietti A; Calabrese L; Pruneri G; Santoro L; Kuper-Hommel M; Tsang R; Zinzani PL; Taghian A; Zucca E; Cavalli F
Ann Oncol; 2009 Dec; 20(12):1993-9. PubMed ID: 19570964
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial.
Oh SY; Kim WS; Lee DH; Kim SJ; Kim SH; Ryoo BY; Kang HJ; Choi YJ; Chung JS; Kim HJ; Suh C
Invest New Drugs; 2010 Apr; 28(2):171-7. PubMed ID: 19421710
[TBL] [Abstract][Full Text] [Related]
30. Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada.
Kuruvilla J; Ewara EM; Elia-Pacitti J; Ng R; Eberg M; Kukaswadia A; Sharma A
Curr Oncol; 2023 Apr; 30(5):4663-4676. PubMed ID: 37232810
[TBL] [Abstract][Full Text] [Related]
31. Repeated localized treatment for extranodal marginal zone lymphoma--case report and review of literature.
Schönknecht CE; Nieder C; Molls M; Astner ST
Anticancer Res; 2011 Nov; 31(11):3935-8. PubMed ID: 22110222
[TBL] [Abstract][Full Text] [Related]
32. Marginal zone B-cell lymphoma: a retrospective immunophenotypic analysis.
Kost CB; Holden JT; Mann KP
Cytometry B Clin Cytom; 2008 Sep; 74(5):282-6. PubMed ID: 18500740
[TBL] [Abstract][Full Text] [Related]
33. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
[TBL] [Abstract][Full Text] [Related]
34. Clinical presentation and management of marginal zone lymphomas.
Thieblemont C
Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
[TBL] [Abstract][Full Text] [Related]
35. Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018).
Auñón C; Sanvisens A; Turon E; Vidal-Vila A; Puigdemont M; Osca-Gelis G; Eraso A; Marcos-Gragera R
Cancer Med; 2023 Jun; 12(11):12343-12353. PubMed ID: 37076996
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune phenomena in untreated and treated marginal zone lymphoma.
Grabska J; Dasanu CA
Expert Opin Pharmacother; 2011 Oct; 12(15):2369-79. PubMed ID: 21679092
[TBL] [Abstract][Full Text] [Related]
37. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
38. Transformation of marginal zone lymphoma (and association with other lymphomas).
Casulo C; Friedberg J
Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
[TBL] [Abstract][Full Text] [Related]
39. Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature.
Gorodetskiy VR; Probatova NA; Radenska-Lopovok SG; Ryzhikova NV; Sidorova YV; Sudarikov AB
Rheumatol Int; 2020 Mar; 40(3):499-506. PubMed ID: 31707561
[TBL] [Abstract][Full Text] [Related]
40. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
Hoffmann M; Kletter K; Becherer A; Jäger U; Chott A; Raderer M
Oncology; 2003; 64(4):336-40. PubMed ID: 12759529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
